Physician

Tommy Jhon Parraga, M.D.

According to 2025 Medicare claims, Tommy Parraga, M.D. (NPI: 1235513672) practices infectious disease in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 35758-2436. Parraga is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Parraga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 43,379 HCPCS/CPT codes, and received $738,859 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 722 prescription claims across 108 beneficiaries totaling $284,444 in drug costs, led by Daptomycin (Daptomycin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $13,018 to $284,444. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$465K$929K2021 Medicare payment: $262,690 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $604,626 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $929,085 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $738,859 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202124611,230$262,690
202259739,578$604,626
2023687108,773$929,085
202459543,379$738,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$178K$356K2015 Drug cost: $13,018 (USD; Tot_Drug_Cst)2016 Drug cost: $14,277 (USD; Tot_Drug_Cst)2017 Drug cost: $74,578 (USD; Tot_Drug_Cst)2018 Drug cost: $32,306 (USD; Tot_Drug_Cst)2019 Drug cost: $61,074 (USD; Tot_Drug_Cst)2020 Drug cost: $79,427 (USD; Tot_Drug_Cst)2021 Drug cost: $107,343 (USD; Tot_Drug_Cst)2022 Drug cost: $356,478 (USD; Tot_Drug_Cst)2023 Drug cost: $248,727 (USD; Tot_Drug_Cst)2024 Drug cost: $284,444 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201536118$13,018
201698287$14,277
201773407$74,578
201875267$32,306
20192179$61,074
202019102$79,427
202135166$107,343
202272605$356,478
202395749$248,727
2024108722$284,444

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes314326$121
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more71115$86
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes3761,093$85
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less77167$42
J0875Injection, dalbavancin, 5 mg243,900$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DaptomycinDaptomycin156995$148,354
ErtapenemErtapenem Sodium115702$53,235
DalvanceDalbavancin Hcl1498$30,305
MeropenemMeropenem25162$15,436
Cefepime HclCefepime Hcl35244$5,855

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Tommy Jhon Parraga, M.D.?

Tedicare shows public-source Medicare data for Tommy Jhon Parraga, M.D. (NPI 1235513672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tommy Jhon Parraga, M.D. have ACO affiliation data?

Tommy Jhon Parraga, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Tommy Jhon Parraga, M.D.?

Tommy Jhon Parraga, M.D. is linked to METRO INFECTIOUS DISEASE CONSULTANTS, LLC (billing NPI 1235125717) in the available physician profile data.

Does Tommy Jhon Parraga, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.